<div id="readability-page-1"><p><span>UnitedHealth Group (NYSE:UNH - Get Free Report)</span> was downgraded by investment analysts at Wall Street Zen from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report issued to clients and investors on Saturday.</p><div><p><span></span><span>Get <strong>UnitedHealth Group</strong> alerts:</span></p></div><ul><li>3 Trades Members of Congress Are Making Right Now</li></ul><p>Other equities research analysts have also issued reports about the stock. Barclays decreased their price target on shares of UnitedHealth Group from $513.00 to $362.00 and set an &#34;overweight&#34; rating on the stock in a report on Thursday, May 15th. Truist Financial  reiterated a &#34;buy&#34; rating and set a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Robert W. Baird reduced their price objective on UnitedHealth Group from $510.00 to $356.00 and set an &#34;outperform&#34; rating on the stock in a research report on Wednesday, May 14th. Raymond James lowered UnitedHealth Group from a &#34;strong-buy&#34; rating to a &#34;market perform&#34; rating in a research note on Wednesday, May 14th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on UnitedHealth Group from $521.00 to $362.00 and set a &#34;buy&#34; rating for the company in a research note on Wednesday, May 14th. One analyst  has rated the stock with a sell rating, seven have issued  a hold rating, seventeen have assigned  a buy rating and one  has issued  a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $441.87.</p><p><b>Check Out Our Latest Stock Report on UNH</b></p><h2>UnitedHealth Group Stock Performance</h2><ul><li>Will Hims &amp; Hers Stock Be Okay After UnitedHealth's Sell-Off?</li></ul><p>Shares of UnitedHealth Group stock opened at $295.37 on Friday. The company has a 50 day moving average of $452.40 and a 200-day moving average of $505.07. The company has a market cap of $267.94 billion, a PE ratio of 19.06, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group has a 1-year low of $248.88 and a 1-year high of $630.73. </p><p>UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the previous year, the business posted $6.91 EPS.  As a group, equities research analysts forecast that  UnitedHealth Group will post 29.54 earnings per share for the current fiscal year. </p><h2>Insider Buying and Selling at UnitedHealth Group</h2><ul><li>UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?</li></ul><p>In related news, Director Kristen Gil purchased 3,700 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director now owns 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the business's stock in a transaction on Friday, May 16th. The shares were purchased at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now directly owns 679,493 shares in the company, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock valued at $31,607,768. Corporate insiders own  0.33% of the company's stock. </p><h2>Hedge Funds Weigh In On UnitedHealth Group</h2><p>Institutional investors have recently modified their holdings of the business. Norges Bank bought a new position in  UnitedHealth Group during the fourth quarter valued at about $6,375,744,000.  GAMMA Investing LLC increased its stake in shares of  UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares during the last quarter.  Nuveen LLC purchased a new position in  UnitedHealth Group in the first quarter valued at approximately $3,846,764,000.  Vanguard Group Inc. increased its position in  UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter.  Finally, Raymond James Financial Inc. purchased a new position in shares of  UnitedHealth Group during the 4th quarter valued at $1,914,740,000. 87.86% of the stock is owned by institutional investors. </p><h2>UnitedHealth Group Company Profile</h2> (Get Free Report)<p>UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.</p><h2>See Also</h2><ul><li>Five stocks we like better than UnitedHealth Group</li><li>Where to Find Earnings Call Transcripts</li><li>Pfizer's 7.5% Dividend: Income Haven or House of Cards?</li><li>5 discounted opportunities for dividend growth investors</li><li>3 Trades Members of Congress Are Making Right Now</li><li>3 Stocks to Consider Buying in October</li><li>TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVVOSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in UnitedHealth Group Right Now?</h2><p>Before you consider UnitedHealth Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.</p><p>While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Wall Street Zen has downgraded UnitedHealth Group (NYSE:UNH) from a "buy" to a "hold" rating. Other analysts have also adjusted their ratings and price targets, with Barclays lowering its target from $513 to $362. The stock currently has a consensus rating of "Moderate Buy" and a price target of $441.87. UnitedHealth's recent earnings report showed an EPS of $7.20, missing estimates. Insider trading activity includes significant purchases by Director Kristen Gil and CEO Stephen J. Hemsley. The stock opened at $295.37, with a market cap of $267.94 billion.</p>

Wall Street Zen Downgrades UnitedHealth Group (NYSE:UNH) to Hold